| 000 | 01303 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250515221432.0 | ||
| 264 | 0 | _c20100812 | |
| 008 | 201008s 0 0 eng d | ||
| 022 | _a1875-5828 | ||
| 024 | 7 |
_a10.2174/156720510791050939 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShineman, D W | |
| 245 | 0 | 0 |
_aAlzheimer's disease drug discovery: Abeta and beyond. _h[electronic resource] |
| 260 |
_bCurrent Alzheimer research _cMay 2010 |
||
| 300 |
_a188-9 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Introductory Journal Article | ||
| 650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
| 650 | 0 | 4 |
_aAmyloid beta-Peptides _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDocosahexaenoic Acids _xpharmacology |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 |
_aFragile X Mental Retardation Protein _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aReceptor, Metabotropic Glutamate 5 |
| 650 | 0 | 4 |
_aReceptors, Metabotropic Glutamate _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSynaptic Transmission _xdrug effects |
| 700 | 1 | _aFillit, H M | |
| 773 | 0 |
_tCurrent Alzheimer research _gvol. 7 _gno. 3 _gp. 188-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/156720510791050939 _zAvailable from publisher's website |
| 999 |
_c19764104 _d19764104 |
||